Taiwan FDA registration c0cfc494ff4aeb9f69052683ca82c7e5

American Pathological Society Red Cell Sedimentation Rate External Quality Control Program - Hematology (Unsterilized)

TW: 美國病理學會紅血球沉降率外部品管計劃-血液學(未滅菌)
Taiwan flagTaiwan·Risk Class 1·COLLEGE OF AMERICAN PATHOLOGISTS;; Alifax, S.r.l.·Registered Oct 22, 2019 – Oct 22, 2029Active
Registration details
Analysis ID
c0cfc494ff4aeb9f69052683ca82c7e5
Customs Code
DHA09402096701
Company information
Manufacturer Country
Italy;;United States
Authorized Representative
HOLLING BIO-PHARMA. CORP.
Product details
Intended Use
Limited to the classification and grading management of medical equipment, quality control materials (analytical and non-analytical) (A.1660) the first level identification range.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1660 Quality control materials (analytical and non-analytical)
Import Information
Input;; Contract manufacturing
Dates and status
Registration Date
Oct 22, 2019
Expiry Date
Oct 22, 2029
About this record

Access comprehensive regulatory information for American Pathological Society Red Cell Sedimentation Rate External Quality Control Program - Hematology (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number c0cfc494ff4aeb9f69052683ca82c7e5 and manufactured by COLLEGE OF AMERICAN PATHOLOGISTS;; Alifax, S.r.l.. The authorized representative in Taiwan is HOLLING BIO-PHARMA. CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices